GKB OphthalmicsBOM:533212 +2.62%62 EBITDA Margin % is 8.04% as of Mar. 2026, which is 45% above its 10-year median of 5.56. GuruFocus rates BOM:533212 with a GF Score™ of 62/100 and a GF Value™ of ₹160.62 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 816 Medical Devices & Instruments companies, GKB Ophthalmics ranks worse than 52.45% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. GKB Ophthalmics's EBITDA for the
three
months ended in Mar. 2026 was ₹24 Mil. GKB Ophthalmics's Revenue for the
three
months ended in Mar. 2026 was ₹298 Mil. Therefore, GKB Ophthalmics's EBITDA margin for the quarter that ended in Mar. 2026 was 8.04%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
GKB Ophthalmics EBITDA Margin % Related Terms
GKB Ophthalmics EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for GKB Ophthalmics's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:533212 vs ISRG, BDX, MDLN: EBITDA Margin % Comparison
For the Medical Instruments & Supplies subindustry, GKB Ophthalmics's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GKB Ophthalmics EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, GKB Ophthalmics's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where GKB Ophthalmics's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GKB Ophthalmics (BOM:533212) has a EBITDA Margin % of 8.04% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on GKB Ophthalmics and its competitors. This is 45% above median its historical median of 5.56. According to the industry distribution chart, GKB Ophthalmics ranks #428 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 52.5%.
Is GKB Ophthalmics' EBITDA Margin % too high?
GKB Ophthalmics' current EBITDA Margin % of 8.04% is 45% above median its 10-year median of 5.56. The Medical Devices & Instruments industry median EBITDA Margin % is 7.46. GKB Ophthalmics' value of 8.04% is 7.8% above this industry median. Based on the distribution chart, GKB Ophthalmics ranks #428 out of 816 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, GKB Ophthalmics has a GF Score™ of 62/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does GKB Ophthalmics' EBITDA Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, GKB Ophthalmics ranks #428 out of 816 companies for EBITDA Margin %. This places GKB Ophthalmics in the lower half of its industry. The industry median EBITDA Margin % is 7.46. GKB Ophthalmics' value of 8.04% is 7.8% above this benchmark. While the company's 10-year median is 5.56 vs. the industry median of 7.46, GKB Ophthalmics has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.46, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. GKB Ophthalmics's current EBITDA Margin % of 8.04% is 7.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on GKB Ophthalmics and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GKB Ophthalmics's current EBITDA Margin % is 8.04%, which is 45% above median its own 10-year median of 5.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GKB Ophthalmics stock overvalued right now?
Based on GuruFocus' analysis, GKB Ophthalmics (BOM:533212) is currently considered Possible Value Trap. The stock's GF Value™ is ₹160.62, compared to a current price of ₹64.29 — trading 60% below its estimated fair value. The current EBITDA Margin % is 8.04%, which is 45% above median its 10-year median of 5.56 and 7.8% above the Medical Devices & Instruments industry median of 7.46. GKB Ophthalmics' overall GF Score™ is 62/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For GKB Ophthalmics (BOM:533212), the current EBITDA Margin % is 8.04% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is GKB Ophthalmics (BOM:533212) Overvalued in 2026?
Based on GuruFocus' analysis, GKB Ophthalmics stock appears to be undervalued.
The current stock price of ₹64.29 is trading 60% below its estimated GF Value™ of ₹160.62.
GuruFocus considers GKB Ophthalmics to be Possible Value Trap.
Key valuation signals for BOM:533212:
EBITDA Margin %: 8.04% (45% above median its 10-year median of 5.56)
GF Value™: ₹160.62 vs. price of ₹64.29 (60% below fair value)
Industry Position: 7.8% above the Medical Devices & Instruments median (#428 of 816)
No single metric tells the full story. See the BOM:533212 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
GKB Ophthalmics Ltd is an India-based company engaged in manufacturing and exporting ophthalmics lenses. It manufactures glass and plastic lenses both semi-finished and finished forms. The other products of the company include Organic lenses, Glass moulds, and Bifocal moulds. The company sells its products in India and also exports globally. Geographically, the majority of its revenue is generated from outside of India.
62GF Score
Get the complete analysis for BOM:533212
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:533212 has been successfully added to your 
